HealthStream, Inc. $HSTM Shares Bought by Copeland Capital Management LLC

Key Points

• Copeland Capital Management increased its stake in HealthStream by 6.2% in Q4, owning 887,553 shares (about 2.99% of the company) valued at roughly $20.48 million.
• HealthStream beat quarterly estimates with $0.18 EPS (vs. $0.16) and $79.71M revenue (vs. $76.21M), but shares were down 2.7% and trade around $20.90 (52‑week range $19.50–$34.13; market cap ≈ $615M).
• The board approved a $10M share repurchase program (up to 1.7% of shares) and raised the quarterly dividend to $0.035 ($0.14 annualized, ~0.7% yield); analysts hold a consensus "Reduce" rating with a $25 target.

Copeland Capital Management LLC grew its position in shares of HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 6.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 887,553 shares of the technology company's stock after acquiring an additional 51,470 shares during the quarter. Copeland Capital Management LLC owned about 2.99% of HealthStream worth $20,476,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Aquatic Capital Management LLC acquired a new stake in HealthStream during the third quarter worth about $40,000. Tower Research Capital LLC TRC increased its stake in HealthStream by 241.4% during the second quarter. Tower Research Capital LLC TRC now owns 2,407 shares of the technology company's stock worth $67,000 after acquiring an additional 1,702 shares during the last quarter. GAMMA Investing LLC increased its stake in HealthStream by 131.4% during the fourth quarter. GAMMA Investing LLC now owns 3,649 shares of the technology company's stock worth $84,000 after acquiring an additional 2,072 shares during the last quarter. State of Wyoming acquired a new stake in HealthStream during the second quarter worth about $106,000. Finally, PNC Financial Services Group Inc. increased its stake in HealthStream by 149.7% during the third quarter. PNC Financial Services Group Inc. now owns 4,760 shares of the technology company's stock worth $134,000 after acquiring an additional 2,854 shares during the last quarter. 69.58% of the stock is currently owned by institutional investors and hedge funds.

HealthStream Stock Down 2.7%

Shares of NASDAQ HSTM opened at $20.90 on Friday. HealthStream, Inc. has a fifty-two week low of $19.50 and a fifty-two week high of $34.13. The business has a 50 day moving average price of $20.93 and a two-hundred day moving average price of $22.87. The firm has a market cap of $614.88 million, a PE ratio of 34.26, a price-to-earnings-growth ratio of 2.47 and a beta of 0.46.

HealthStream (NASDAQ:HSTM - Get Free Report) last issued its quarterly earnings data on Monday, February 23rd. The technology company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.02. HealthStream had a return on equity of 5.98% and a net margin of 6.03%.The firm had revenue of $79.71 million during the quarter, compared to analyst estimates of $76.21 million. On average, analysts anticipate that HealthStream, Inc. will post 0.73 earnings per share for the current year.

HealthStream declared that its board has approved a share repurchase program on Friday, March 13th that permits the company to buyback $10.00 million in outstanding shares. This buyback authorization permits the technology company to buy up to 1.7% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's leadership believes its stock is undervalued.

HealthStream Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Monday, March 9th were paid a dividend of $0.035 per share. This is a boost from HealthStream's previous quarterly dividend of $0.03. The ex-dividend date was Monday, March 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.7%. HealthStream's payout ratio is 22.95%.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Canaccord Genuity Group set a $25.00 price target on HealthStream in a research note on Thursday, January 8th. Citigroup restated a "market perform" rating on shares of HealthStream in a research note on Tuesday, January 6th. Finally, Weiss Ratings lowered HealthStream from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Wednesday, March 18th. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, HealthStream presently has a consensus rating of "Reduce" and a consensus target price of $25.00.

HealthStream Company Profile

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream's platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company's core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.

Want to see what other hedge funds are holding HSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthStream, Inc. (NASDAQ:HSTM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.